Qiagen appoints new supervisory board chairman

By LabPulse.com staff writers

August 25, 2020 -- Qiagen has appointed Lawrence Rosen as the new chairman of its supervisory board, effective immediately. The news comes in the wake of the failure of Thermo Fisher's proposed acquisition of Qiagen.

Rosen replaces Håkan Björklund, PhD, who decided to step down as chairman as well as a member of the supervisory board. Qiagen also announced Björklund will not stand for reelection at the next annual general meeting planned for June 2021.

Rosen has been a member of Qiagen's supervisory board since 2013 and also serves on the supervisory board of Lanxess. He was a member of the board of management and chief financial officer (CFO) of Deutsche Post DHL in Germany until September 2016. Prior to that post he served as Fresenius Medical Care's CFO.

Qiagen also announced it reduced the number of supervisory directors to six.

Thermo Fisher's acquisition of Qiagen falls short
Thermo Fisher Scientific has terminated its acquisition of Qiagen after the company was unable to secure the number of shares needed to proceed with the...
Thermo Fisher increases Qiagen acquisition offer
Thermo Fisher Scientific and Qiagen have amended their acquisition agreement with an increase from the original offer price of 39 euros ($44.61 U.S.)...
Qiagen launches therascreen BRAF test
Qiagen is launching a therascreen BRAF test as a companion diagnostic to Pfizer's targeted drug Braftovi in metastatic colorectal cancer.
Qiagen gets FDA nod for syndromic SARS-CoV-2 test
Qiagen has received emergency use authorization from the U.S. Food and Drug Administration for its QIAstat-Dx diagnostic kit, a syndromic test for detecting...
Qiagen taps CEO, ships coronavirus tests to U.S.
Qiagen has made it official: Thierry Bernard has been named the company's permanent CEO after serving in an interim capacity since October 2019.

Copyright © 2020 LabPulse.com

Last Updated ls 8/24/2020 4:46:29 PM



Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.
Email